Direct and spillover promotional effects on drug prescriptions: Comparing differential physician- vs. patient-focused promotional effects
Open Access
- 27 October 2025
- journal article
- research article
- Published by Springer Nature in Journal of the Academy of Marketing Science
- Vol. 54 (2) , 381-401
Abstract
We examine the impact of marketing strategies on new prescriptions. Companies promote drugs to both physicians, prescribing medications, and patients. We examine two antidepressant classes—SSRIs and SNRIs—highlighting two key findings: (1) Physician-targeted promotions, such as detailing, samples, and journal advertising, are more effective than patient-targeted promotions, direct-to-consumer advertising (DTCA), in their direct effects on drug adoption. (2) Physician-focused promotions exhibit stronger spillover effects on competing brands than patient-focused promotions. We emphasize that physicians, as agents with medical expertise, are the primary decision-makers, while patients have limited influence on their prescriptions. Agency theory provides a rationale for the differential promotional effects, as the interests of physicians and patients diverge, and physicians have superior medical expertise and knowledge on a drug’s efficacy and safety. Our findings provide evidence for companies to reallocate their resources from DTCA to physician-targeted promotions. This policy leads to lower costs of patent-protected drugs for patients.Keywords
Funding Information
- University of North Carolina at Charlotte
This publication has 49 references indexed in Scilit:
- How product complexity affects consumer adoption of new products: The role of feature heterogeneity and interrelatednessJournal of the Academy of Marketing Science, 2023
- Effects of advertising and R&D on spillovers from a rival’s bankruptcyJournal of the Academy of Marketing Science, 2023
- The value of context-specific studies for marketingJournal of the Academy of Marketing Science, 2022
- Information Asymmetry in Hospitals: Evidence of the Lack of Cost Awareness in CliniciansApplied Health Economics and Health Policy, 2022
- Return on Media Models2021
- Two-Sided Information Asymmetry in the Healthcare IndustryInternational Advances in Economic Research, 2019
- Pharmaceutical Industry–Sponsored Meals and Physician Prescribing Patterns for Medicare BeneficiariesJAMA Internal Medicine, 2016
- Shared Decision Making: A Model for Clinical PracticeJournal of General Internal Medicine, 2012
- A meta-analytic review of opportunism in exchange relationshipsJournal of the Academy of Marketing Science, 2007
- Understanding Firm, Physician and Consumer Choice Behavior in the Pharmaceutical IndustryMarketing Letters, 2005